BioNTech Announces Appointment of Kylie Jimenez to Management Board as Chief People Officer 28 January
BioNTech Provides Strategic Business Update and Outlines 2026 Areas of Focus at 44th Annual J.P. Morgan Healthcare Conference 12 January
BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field 18 December 2025
